State Street Corp Nuvectis Pharma, Inc. Put Options Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding NVCT
# of Institutions
40Shares Held
2.12MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$3.9 Million5.37% of portfolio
-
Black Rock Inc. New York, NY373KShares$2.59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA299KShares$2.07 Million0.0% of portfolio
-
Baldwin Brothers LLC169KShares$1.17 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA135KShares$933,6240.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $102M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...